Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.90
- Piotroski Score 4.00
- Grade Outperform
- Symbol (SDGR)
- Company Schrödinger, Inc.
- Price $18.81
- Changes Percentage (-0.87%)
- Change -$0.17
- Day Low $18.76
- Day High $19.23
- Year High $38.00
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $29.00
- High Stock Price Target $30.00
- Low Stock Price Target $27.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.00
- Trailing P/E Ratio -10.87
- Forward P/E Ratio -10.87
- P/E Growth -10.87
- Net Income $40.72 M
Income Statement
Quarterly
Annual
Latest News of SDGR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Schrödinger, Inc. (SDGR): A Bull Case Theory
Schrödinger, Inc. (SDGR) is positioned as a key player in software and biotech integration, offering innovative AI-driven drug discovery solutions....
By Yahoo! Finance | 1 month ago -
Compared to Estimates, Schrodinger (SDGR) Q2 Earnings: A Look at Key Metrics
Schrodinger, Inc. reported a revenue of $47.33 million for the quarter ending June 2024, a 34.5% increase from the previous year. The EPS was -$0.74 compared to -$0.21 last year, exceeding analyst exp...
By Yahoo! Finance | 3 months ago -
We're Not Very Worried About Schrödinger's (NASDAQ:SDGR) Cash Burn Rate
Even with losses, shareholders can profit by investing in undervalued businesses like Salesforce.com. Analyzing Schrödinger's cash burn, it had a 2.7-year cash runway in 2024....
By Yahoo! Finance | 3 months ago
